At last, a drug to slow down Alzheimer's

Eisai Co, a Tokyo-based pharmaceutical company with a family bent and market capitalisation of $14 billion, crossed the finish line before behemoths valued nearly 20-fold higher, including industry leaders Roche Holding AG and Eli Lilly& Co
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news